Prevention of rheumatic fever: a statement for health professionals by the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the young, the American Heart Association

Pediatr Infect Dis J. 1989 May;8(5):263-6.
No abstract available

MeSH terms

  • American Heart Association
  • Drug Administration Schedule
  • Endocarditis, Bacterial / prevention & control
  • Humans
  • Penicillins / administration & dosage
  • Penicillins / therapeutic use
  • Primary Prevention
  • Rheumatic Fever / drug therapy
  • Rheumatic Fever / prevention & control*
  • Streptococcal Infections / diagnosis
  • Streptococcal Infections / drug therapy
  • Time Factors
  • United States

Substances

  • Penicillins